Healthcare & Life Sciences

Hervolution Therapeutics (Inprother ApS)

activeseries-a
series-a
Stage
2025
Founded
3
Investors

About

Inprother ApS develops therapeutics focused on harnessing the HERV (human endogenous retrovirus) biology for novel disease treatments.

Explore Hervolution Therapeutics (Inprother ApS)'s full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.